The Biggest Psychedelic News Stories of the Week – May 5
The psychedelic news scene continues to be constantly evolving, with new developments emerging from various states across the country.
The psychedelic news scene continues to be constantly evolving, with new developments emerging from various states across the country.
Here’s how to become a research subject for psilocybin, LSD, MDMA, ibogaine, DMT and 5-MeO-DMT studies.
A direct comparison between the subjective effects, onset time, mystical experience and research of shrooms vs. LSD.
For all the benefits in taking psychedelic substance like psilocybin, there is the risk of having a bad trip.
New paper published in Science proposes expert solutions for regulatory challenges in the psychedelic field.
Episode 1 of PSYC Taboo: Sex and Psychedelics – Pleasure is Your Divine Right! explores the connection between sex and psychedelics.
Some of the biggest psychedelic news this week include the Colorado Senate passing a bill to regulate psychedelics.
Psilomethoxin is claimed to possess distinct characteristics and outcomes when compared to conventional psychedelics.
Is it safe to mix psychedelics and antidepressants like SSRIs? In this article, we look at the research to assess the potential risks.
Psychedelics and antibiotics: Can psychedelic drugs safely interact with common antibiotics, or would this put users at risk?
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.